Our Current Studies

Now Enrolling

Blood Collection study

Inclusion Criteria:

  • Ability to understand and provide written informed consent
  • Age ≥ 50 years
  • Current or Former Smoker
  • ≥ 20 pack-years (pack years = number of packs per day X number of years smoked)
  • Prior thoracic imaging (computed tomography (CT)) within 12 months of enrollment OR Planned thoracic imaging (CT) as part of standard of care within 6 weeks of enrollment
Enroll

Urine Collection Study - Healthy

Inclusion Criteria:

  • Age ≥ 21 years
  • Recently been seen by a Primary care Doctor in the last year
 
Enroll

Asthma

Inclusion Criteria:

 

    • The participant is an adult female or male ≥18 years of age.
    • The participant has a diagnosis of asthma for at least 6 months and has been stable without exacerbation or change in medications for at least 1 month..
    • Current Asthma Therapy: The participant has been maintained for at least 1 month on stable doses of:
      • medium or high dose inhaled corticosteroids (ICS)±another controller.
      • any fixed dose combination ICS (low, medium, or high) with long-acting beta agonist (LABA)±another controller.
Enroll

Gastroparesis

Inclusion Criteria:

 

  • Adult patients with diabetic or idiopathic gastroparesis
  • Symptoms consistent with gastroparesis (nausea, vomiting, early satiety, post-prandial fullness, and abdominal pain)
  • Documented evidence of no mechanical obstruction
  • Delayed gastric emptying as demonstrated by gastric scintigraphy or breath test 
  •  
Enroll

Bronchiectasis

Inclusion Criteria:

 

    • The participant is an adult female or male 18-85 years of age.
    • Have symptoms of bronchiectasis, such as persistent cough, chronic sputum (mucus/saliva mix) production, fatigue, difficulty breathing, or frequent respiratory infections
    • Have previously taken antibiotic medication for your lung condition
Enroll

Gastroparesis

Inclusion Criteria:

·       Diagnosed with gastroparesis

·       Demonstrated delayed gastric emptying

·       Presence of moderate to severe nausea

·       Body Mass Index (BMI) of ≥18 and ≤40 kg/m2

Enroll

COPD

Inclusion criteria:

 

 

  • Participants with a physician
    diagnosis of COPD who meet the following criteria at screening:
    • Current or former smokers with a smoking history of ≥10 pack-years.
    • Patient-reported history of signs and symptoms of chronic bronchitis (chronic productive cough) for 3 months in the year up to screening in the absence of other known causes of chronic cough.
    • Documented history of high exacerbation risk defined as exacerbation history of ≥2 moderate or ≥1 severe within the year prior to inclusion.
    • Background triple therapy (ICS + LABA + LAMA) for 3 months prior to randomization with a stable dose of medication for ≥1 month prior to Visit 1; Double therapy (LABA + LAMA) allowed if ICS is contraindicated.
Enroll

COPD

Inclusion Criteria:

  • Documented physician diagnosis of COPD for at least 12 months
  • History of frequent exacerbations, defined as having had two or more moderate or severe exacerbations occurring within a 12-month period in the 24 months prior to screening
  • Current or former smoker with a minimum of 10 pack-year history
  • History of one of the following combinations of optimized, stable, standard-of-care COPD maintenance therapy for at least 4 weeks prior to screening, with no anticipated changes in therapy prior to initiation of study drug and throughout the study: Inhaled corticosteroid (ICS) plus long-acting beta-agonist (LABA); Long-acting muscarinic antagonist (LAMA) plus LABA; ICS plus LAMA plus LABA
Enroll

Narcolepsy

Inclusion Criteria:

 

  • Male or female subjects between 15 and 75 years of age, inclusive
  • Primary diagnosis of narcolepsy with cataplexy
  • Willing and able to comply with the study requirements
Enroll